Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
21.27
+0.82 (4.01%)
At close: Feb 21, 2025, 4:00 PM
21.35
+0.08 (0.38%)
After-hours: Feb 21, 2025, 7:49 PM EST
Immunovant Market Cap
Immunovant has a market cap or net worth of $3.61 billion as of February 21, 2025. Its market cap has decreased by -31.78% in one year.
Market Cap
3.61B
Enterprise Value
3.24B
1-Year Change
-31.78%
Ranking
Category
Stock Price
$21.27
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $3.61B, an increase of 2,804.87%. That is a compound annual growth rate of 81.08%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |